- by Written by TTPI
SX-ELLA Stent Esophageal Degradable BD - BD STENT
- Excellent flexibility
- Radiopaque markers
- Splittable olive tip
Stent system for treatment of benign esophageal strictures.
BD - after deployment 4 weeks
BD Stent is designed for relieving benign esophageal lesions, namely:
- Stenosis (peptic, anastomotic or caustic) refractory to standard therapy,
- Achalasia refractory to standard therapy.
Inability to pass the 9.4 mm (28 F) delivery system through the stricture
Benign stricture in the upper part of esophagus too close to the cricopharyngeal muscle
Patients with benign strictures due to previously performed laryngectomy
Features / Benefits
- Stent integrity and radial force of the stent is maintained for 6 – 8 weeks following implantation / Extended period of dilation compared to conventional methods
- Stent disintegration occurs 11 - 12 weeks following implantation / No need for removal
- Dual “flared ends” stent design / Reduced migration rates
- Radiopaque markers at both stent ends / Accurate stent positioning
The stent is delivered sterile and packed separately from the delivery system. It is manually loaded into the delivery system immediately prior to implantation.
The use of a 0.035” (0.89 mm) / 220 cm stiff guide wire is recommended.
- The pH influences the process of degradation of the stent. Low pH (e.g. due to GE reflux) accelerates the degradation.